Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.

Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE.

Thromb Haemost. 2001 Sep;86(3):791-9.

PMID:
11583309
3.

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.

Juhan-Vague I, Alessi MC, Vague P.

Ann Med. 1996 Aug;28(4):371-80. Review.

PMID:
8862693
4.

Von Willebrand factor in diabetic angiopathy.

Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.

Diabetes Metab. 1998 Sep;24(4):327-36. Review.

PMID:
9805643
5.

Dyslipidaemia and coagulation defects of insulin resistance.

Frohlich J, Steiner G.

Int J Clin Pract Suppl. 2000 Oct;(113):14-22. Review.

PMID:
11965826
6.

Type 2 diabetes: an atherothrombotic syndrome.

Dunn EJ, Grant PJ.

Curr Mol Med. 2005 May;5(3):323-32. Review.

PMID:
15892651
7.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
8.

[Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].

Mudríková T, Tkác I, Takác M.

Vnitr Lek. 1994 Apr;40(4):250-4. Review. Slovak.

PMID:
8184588
9.

[Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. II. PAI-1 in insulin resistant conditions].

Galajda P, Sutarík L, Vladár L, Stasko J, Kubisz P, Mokán M.

Vnitr Lek. 1998 Feb;44(2):111-4. Review. Slovak.

PMID:
9820087
10.

Diabetes mellitus: a hypercoagulable state.

Carr ME.

J Diabetes Complications. 2001 Jan-Feb;15(1):44-54. Review.

PMID:
11259926
11.

von Willebrand factor, endothelial cell damage and atherosclerosis.

Blann AD, McCollum CN.

Eur J Vasc Surg. 1994 Jan;8(1):10-5. Review.

PMID:
8307205
12.

[Diabetes, coagulation and vascular events].

Nenci GG, Paliani U.

Recenti Prog Med. 2000 Feb;91(2):86-90. Review. Italian.

PMID:
10748654
13.

[Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. I. Regulation of PAI-1 levels].

Galajda P, Sutarík L, Vladár L, Stasko J, Kubisz P, Mokán M.

Vnitr Lek. 1997 Dec;43(12):804-8. Review. Slovak.

PMID:
9601894
14.

[Tissue plasminogen activator and diabetes mellitus].

Galajda P, Martinka E, Kubisz P, Mokán M.

Vnitr Lek. 1998 Nov;44(11):661-4. Review. Slovak.

PMID:
10422507
15.

[The heart and metabolic syndrome].

Tschoepe D, Roesen P, Scherbaum WA.

Z Kardiol. 1999 Mar;88(3):215-24. Review. German. Erratum in: Z Kardiol 1999 May;88(5):380.

PMID:
10355072
16.

Dyslipoproteinemia and diabetes.

Orchard TJ.

Endocrinol Metab Clin North Am. 1990 Jun;19(2):361-80. Review.

PMID:
2192878
17.

Associations Between Inflammatory Markers, Hemostatic Markers, and Microvascular Complications in 182 Chinese Patients With Type 2 Diabetes Mellitus.

Zheng N, Shi X, Chen X, Lv W.

Lab Med. 2015 Summer;46(3):214-20. doi: 10.1309/LMF8R2KSTOW3FLKD. Review.

PMID:
26199261
18.

Role of insulin in regulation of lipoprotein metabolism in diabetes.

Reaven GM, Chen YD.

Diabetes Metab Rev. 1988 Nov;4(7):639-52. Review. No abstract available.

PMID:
3069396
19.

Studies on the pathogenesis of diabetic vascular disease.

Colwell JA.

J S C Med Assoc. 1981 Jun;77(6):267-72. Review. No abstract available.

PMID:
7022022

Supplemental Content

Support Center